Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
Han Ah Lee, Seung Up Kim, Yeon Seok Seo, et al.
Hepatology Communications (2023) Vol. 7, Iss. 2, pp. e0011-e0011
Open Access | Times Cited: 10

Showing 10 citing articles:

Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States
Kevin Pak, Ryan Sachar, Sammy Saab
Digestive Diseases and Sciences (2025)
Closed Access
Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase
Jian Wang, Li Zhu, Zhiyi Zhang, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
“Treat-all" Strategy for Patients with Chronic Hepatitis B Virus Infection in China: Are We There Yet?
Mengyang Zhang, Yuanyuan Kong, Xiaoqian Xu, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 12, Iss. 6, pp. 589-593
Open Access | Times Cited: 2
The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
Moon Haeng Hur, Jeong‐Hoon Lee
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 363-366
Open Access | Times Cited: 2
Estimating the key outcomes and hepatocellular carcinoma risk in patients in immune‐tolerant phase of chronic hepatitis B virus infection: A systematic review and meta‐analysis
Min Liu, Taixue Zhao, Jinyang Zhang, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access
Natural History and Prognosis of Chronic Hepatitis B Patients in the Indeterminate Phase
Hao Jiang, Hongsheng Yu, Yinan Huang, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access
Probability analysis of hepatocellular carcinoma in hepatitis patients in the gray zone
Jianna Zhang, Sijie Yu, K. Zhu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Novel biomarkers for chronic hepatitis B management
Tai‐Chung Tseng
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access
The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?
Wen‐Juei Jeng, Grace Lai‐Hung Wong
Hepatology Communications (2023) Vol. 7, Iss. 3, pp. e0060-e0060
Open Access
Management of Immune-Tolerant Patients with Chronic HBV Infection
Tai‐Chung Tseng, Hung-Yao Lin, Jia‐Horng Kao
Current Hepatology Reports (2023) Vol. 22, Iss. 3, pp. 130-137
Closed Access
Page 1

Scroll to top